Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Treatment of digital vasospastic disease with the calcium-entry blocker nifedipine.

Nilsson H, Jonasson T, Ringqvist I.

Acta Med Scand. 1984;215(2):135-9.

PMID:
6702493
2.
3.

Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon).

Kahan A, Weber S, Amor B, Menkes CJ, Saporta L, Hodara M, Guerin F, Degeorges M.

Eur Heart J. 1983 May;4 Suppl C:123-9.

PMID:
6352267
4.

[Treatment of Raynaud's syndrome with calcium entry blockers].

Shcherbakov AB, Guseva NG, Mach ES.

Ter Arkh. 1987;59(4):89-92. Russian.

PMID:
3296288
5.

Nifedipine as a therapeutic modality for Raynaud's phenomenon.

Winston EL, Pariser KM, Miller KB, Salem DN, Creager MA.

Arthritis Rheum. 1983 Oct;26(10):1177-80.

PMID:
6626276
6.

[The use of calcium antagonists in the treatment of ocular circulation symptoms in the framework of a vasospastic syndrome].

Gasser P, Flammer J, Mahler F.

Schweiz Med Wochenschr. 1988 Feb 13;118(6):201-2. German.

PMID:
3363311
7.
8.

[Controlled study of nifedipine in the treatment of Raynaud's phenomenon].

Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M.

Rev Rhum Mal Osteoartic. 1982 Apr;49(5):337-43. French.

PMID:
6285445
9.

Digital and radial artery blood flow in patients with Raynaud's phenomenon in response to nifedipine.

Morgan RH, Psaila JV, Davies WT, Carolan G, Woodcock JP.

Eur J Vasc Surg. 1987 Dec;1(6):403-8.

PMID:
3503035
10.

Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.

Maricq HR, Weinrich MC, Valter I, Palesch YY, Maricq JG.

J Rheumatol. 1996 Dec;23(12):2068-78.

PMID:
8970043
11.

Effect of local cold provocation on systolic blood pressure and skin blood flow in the finger.

Bornmyr S, Castenfors J, Evander E, Olsson G, Hjortsberg U, Wollmer P.

Clin Physiol. 2001 Sep;21(5):570-5.

PMID:
11576158
12.

Nifedipine in the treatment of Raynaud's syndrome.

Aldoori M, Campbell WB, Dieppe PA.

Cardiovasc Res. 1986 Jun;20(6):466-70.

PMID:
3536108
13.
14.

Rational use of calcium-channel antagonists in Raynaud's phenomenon.

Sturgill MG, Seibold JR.

Curr Opin Rheumatol. 1998 Nov;10(6):584-8.

PMID:
9812220
15.

Nifedipine and arotinolol in combination for accelerated-malignant hypertension: results of one year follow-up.

Nakamoto H, Nemoto H, Sugahara S, Okada H, Suzuki H.

Hypertens Res. 1999 Jul;22(2):75-80.

16.
17.

Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.

Ettinger WH, Wise RA, Schaffhauser D, Wigley FM.

Am J Med. 1984 Sep;77(3):451-6.

PMID:
6540986
19.

Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.

Dey HM, Soufer R, Hoffer P, Wackers FJ, Black HR.

Am J Hypertens. 1996 Jun;9(6):598-606.

PMID:
8783785
20.

The effect of felodipine on cold-induced digital vasospasm.

Nilsson H, Blychert E, Jonasson T, Leppert J, Ringqvist I.

J Cardiovasc Pharmacol. 1990;15 Suppl 4:S108-10.

PMID:
1693714

Supplemental Content

Support Center